Qlucore AB Stock

Equities

QCORE

SE0016829824

Software

Delayed Nasdaq Stockholm 03:00:04 2024-04-29 EDT 5-day change 1st Jan Change
8 SEK -1.23% Intraday chart for Qlucore AB -4.76% +4.58%

Financials

Sales 2022 22.5M 2.06M 2.81M Sales 2023 31.45M 2.88M 3.93M Capitalization 53.98M 4.94M 6.75M
Net income 2022 -11M -1.01M -1.38M Net income 2023 -15M -1.37M -1.88M EV / Sales 2022 0.95 x
Net cash position 2022 92.64M 8.48M 11.58M Net cash position 2023 65.27M 5.98M 8.16M EV / Sales 2023 -0.36 x
P/E ratio 2022
-9.77 x
P/E ratio 2023
-3.39 x
Employees 22
Yield 2022 *
-
Yield 2023
-
Free-Float 45.57%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.23%
1 week-4.76%
Current month-6.98%
1 month-7.51%
3 months+1.27%
6 months-18.78%
Current year+4.58%
More quotes
1 week
7.90
Extreme 7.9
8.20
1 month
7.90
Extreme 7.9
9.05
Current year
6.80
Extreme 6.8
11.50
1 year
5.75
Extreme 5.75
13.50
3 years
5.75
Extreme 5.75
58.00
5 years
5.75
Extreme 5.75
58.00
10 years
5.75
Extreme 5.75
58.00
More quotes
Managers TitleAgeSince
Founder 56 06-12-04
Director of Finance/CFO - 22-01-31
Chief Tech/Sci/R&D Officer - 22-02-06
Members of the board TitleAgeSince
Director/Board Member 65 18-12-31
Chairman 70 08-12-31
Founder 66 06-12-04
More insiders
Date Price Change Volume
24-04-29 8 -1.23% 100
24-04-26 8.1 0.00% 500
24-04-25 8.1 -0.61% 600
24-04-24 8.15 -2.98% 3,241
24-04-22 8.4 -0.59% 161

Delayed Quote Nasdaq Stockholm, April 29, 2024 at 03:00 am

More quotes
Qlucore AB is a Sweden-based provider of new generation of intuitive bioinformatics software for research and precision and companion diagnostics. Its mission is to make it easier to analyze the vast amounts of complex data generated by innovations in genomics and proteomics. This is done by providing visualization-based analysis data tools for bioinformatics for research and precision diagnostics. The tools are so easy to use that researchers, technicians and doctors can easily interpret and explore their data sets. Qlucore Diagnostics software is a platform for multi-omics companion and precision diagnostics. AI-driven, disease-specific machine learning-based classification models are combined with patient-friendly visualizations in an easy-to-use and cost-effective software solution that integrates with a wide range of data-generating technologies and instruments. Qlucore was founded in 2007 by researchers at the departments of mathematics and clinical genetics at Lund University.
Calendar
More about the company